ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – BLRX
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioLineRx